opicinumab (biib033) is a fully human monoclonal antibody designed for the treatment of multiple sclerosis, acute optic neuritis (aon), and other associated demyelinating diseases. a biologic drug, it is designed to function as a lingo-1 protein antagonist, known as “anti-lingo-1”.